Drug Watch. Hepatitis C virus (HCV) infection.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. CV3
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012 AND VI 47 AND IP 3
Results: 23
1
2
Policy Watch. FDA user fee renewal addresses drug shortages, new drug development.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 125
- By:
- Publication type:
- Article
3
Meeting Coverage. Mobile health service serves as catalyst to maternal, infant well-being.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 124
- By:
- Publication type:
- Article
4
Meeting Coverage. Service encourages teens to text health-related questions.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 124
- By:
- Publication type:
- Article
5
Meeting Coverage. Clopidogrel/aspirin not effective for prevention of recurrent stroke.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 123
- Publication type:
- Article
6
Meeting Coverage. Anticlotting agents offer similar prevention rates of stroke, death in heart failure patients with normal heart rhythm.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 123
- By:
- Publication type:
- Article
7
Medication Safety and Reliability.Poorly controlled diabetes may lead to hearing loss in women.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 122
- Publication type:
- Article
8
News Capsules. FDA unveils guidance for biosimilar development.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 96
- By:
- Publication type:
- Article
9
Medication Safety and Reliability. Coadministration of boceprevir with ritonavir-boosted HIV protease inhibitors could reduce drugs' effectiveness.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 105
- Publication type:
- Article
10
Medication Safety and Reliability. FDA: C. difficile-associated diarrhea may be associated with proton pump inhibitors.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 105
- Publication type:
- Article
11
Teriflunomide: An orally administered disease-modifying drug for the treatment of multiple sclerosis.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 97
- By:
- Publication type:
- Article
12
News Capsules. Vorapaxar may reduce heart attack and stroke, but raises bleeding risk.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 96
- Publication type:
- Article
13
Second-generation antipsychotics: A review of recently approved agents and drugs in the pipeline.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 106
- By:
- Publication type:
- Article
14
News Capsules. 2012 vaccination schedules published for children, adults.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 92
- By:
- Publication type:
- Article
15
News Capsules. Immunotherapy shown to extend life expectancy in metastatic prostate cancer.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 92
- By:
- Publication type:
- Article
16
News Capsules. Benefit design continues to be influenced by rising medical, pharmacy costs.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 91
- By:
- Publication type:
- Article
17
News Capsules. Racial/ethnic disparities exist in the diagnosis, treatment of depression.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 90
- Publication type:
- Article
18
News Capsules. Increased awareness, better drug therapies drive mental health medication use.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 89
- By:
- Publication type:
- Article
19
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 88
- Publication type:
- Article
20
FDA Drug Approvals. First-time generic approvals.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 88
- Publication type:
- Article
21
FDA Drug Approvals. New indication.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 87
- Publication type:
- Article
22
FDA Drug Approvals. New molecular entitity.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 87
- Publication type:
- Article
23
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 3, p. 87
- Publication type:
- Article